N6-Acetyladenosine
        N6-Acetyladenosine, a remarkable biomedical commodity, manifests its indispensable role in the oncological landscape. Holding the prowess as a nucleoside analog, it exerts a profound hindrance upon the inexorable growth of malignant cells, effectively triggering their untimely demise through apoptosis induction. The intrinsic antitumor attributes exhibited by N6-Acetyladenosine unmask its promising potential, thereby rendering it a plausible candidate for incorporation into targeted chemotherapy protocols capable of subduing a diverse array of tumor classifications.
    * Please kindly note that our products are not to be used for therapeutic purposes and cannot be sold to patients.
    
        
                    
                    
                        Synonyms
                        Adenosine, N-acetyl-; N-Acetyladenosine; N6-acetyl-adenosine; N-(9-((2R,3R,4S,5R)-3,4-Dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-9H-purin-6-yl)acetamide; N-(9-β-D-Ribofuranosyl-9-H-purin-6-yl)-acetamide
                     
                    
                    
                        IUPAC Name
                        N-[9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]purin-6-yl]acetamide
                     
                    
                    
                        Molecular Formula
                        C12H15N5O5
                     
                    
                        Canonical SMILES
                        CC(=O)NC1=C2C(=NC=N1)N(C=N2)C3C(C(C(O3)CO)O)O
                     
                    
                        InChI
                        InChI=1S/C12H15N5O5/c1-5(19)16-10-7-11(14-3-13-10)17(4-15-7)12-9(21)8(20)6(2-18)22-12/h3-4,6,8-9,12,18,20-21H,2H2,1H3,(H,13,14,16,19)/t6-,8-,9-,12-/m1/s1
                     
                    
                        InChIKey
                        SLLVJTURCPWLTP-WOUKDFQISA-N
                     
                    
                    
                    
                        Solubility
                        Soluble in DMF, DMSO, Ethanol, Methanol
                     
                    
                        Appearance
                        White to Off-white Powder
                     
                    
                    
         
        
            Chemical Structure:

         
     
        
            Reference Reading
            1. N6-Acetyladenosine: a new modified nucleoside from Methanopyrus kandleri tRNA
Anselm Sauerwald, Devarasetty Sitaramaiah, James A McCloskey, Dieter Söll, Pamela F Crain. FEBS Lett. 2005 May 23;579(13):2807-10. doi: 10.1016/j.febslet.2005.04.014.
Post-transcriptionally modified nucleosides are constituents of transfer RNA (tRNA) that are known to influence tertiary structure, stability and coding properties. Modifications in unfractionated tRNA from the phylogenetically unique archaeal methanogen Methanopyrus kandleri (optimal growth temperature 98 degrees C) were studied using liquid chromatography-mass spectrometry to establish the extent to which they might differ from those of other methanogens. The exceptionally diverse population of nucleosides included four new nucleosides of unknown structure, and one that was characterized as N(6)-acetyladenosine, a new RNA constituent. The nucleoside modification pattern in M. kandleri tRNA is notably different from that of other archaeal methanogens, and is closer to that of the thermophilic crenarchaeota.
         
    
    
    Our Products
    
        BOC Sciences is a leading provider of DNA and RNA products and services that meet the needs of
        researchers and pharmaceutical companies worldwide. Its broad product portfolio includes various types of
        oligonucleotides, DNA/RNA synthesis feedstocks, RNA interference tools, and advanced drug delivery systems, among
        others. Designed to promote cutting-edge research and innovative therapeutic solutions, at BOC Sciences you are sure
        to find the right product for you.